ADVANSIX ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS

AdvanSix Inc. (ASIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release ADVANSIX ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS 2Q26 Sales of $421 million, up 3% versus prior year 2Q26 Earnings Per Share of $0.12; Adjusted Earnings Per Share of $0.19 2Q26 Cash Flow from Operations of $10 million Parsippany, N.J., August 7,

Event · Earnings
Also in this documentDividend · regular · $0.16Guidance · reaffirm · $75M–$95M

Facts are quoted from the filing text and checked against it.

Original reporting
Published Aug 7, 2026, 10:29 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 10:55 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ASIX
Bearish
high confidence
Mentioned
$ASIX
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ASIXBearishMed
01

Why it matters

Key trading inputs are the magnitude of YoY declines in net income, adjusted EBITDA, and operating cash flow, plus management’s 3Q26 sequential pricing expectation for ammonium sulfate and a 2H26 cash-flow improvement plan tied to capex and working capital.

02

Market read

Traders will likely reprice ASIX around margin and cash-flow deterioration in Plant Nutrients, while also weighing management’s guidance for sequential pricing and 2H26 cash-flow improvement.

03

What to watch

Plant Nutrients volume fell short due to farmer economics, so the market may be over-weighting demand weakness versus potential normalization; also 45Q carbon capture tax credits timing affected prior-year comparability and could distort trend interpretation.

Relevance 7/10Novelty 8/10Timing: pre-market today (8/7) with same-day earnings release and dividend record/payment dates

Background

This is an SEC 8-K filing with Exhibit 99.1 covering AdvanSix’s second quarter 2026 results and forward-looking outlook, including a declared quarterly dividend and conference call details.

Company-level read

Ticker impact

$ASIXBearishHigh confidence
Context

AdvanSix reported 2Q26 sales of $421.3M (+3% YoY) but sharply lower net income and adjusted EBITDA, plus 3Q26 outlook on ammonium sulfate pricing.

Expected impact

Near-term bias likely negative as traders focus on weaker earnings/cash flow and the expectation of 3Q26 sequential pricing decline, despite some offsetting pricing tailwinds.

Evidence & confidence

The filing provides concrete quarterly P&L and cash-flow deltas versus prior year, and it includes specific forward-looking statements for 3Q26 pricing dynamics and 2H26 cash-flow improvement drivers.

Market effects

Plant Nutrients and fertilizer input pricing dynamics (ammonium sulfate, sulfur costs) are highlighted, which can influence sentiment across adjacent ag-chem and industrial chemical names.

Primarily North American fertilizer supply chain exposure via ammonium sulfate fill program and domestic pricing expectations.

Limited direct global read-through, but benzene/propylene and nitrogen pricing references can matter for broader chemical input cost expectations.

Counterpoint

The company emphasizes pricing mechanisms and expects 2H26 cash-flow improvement from reduced capex run-rate and working-capital tailwinds, which could offset near-term earnings weakness.

Key entities

  • AdvanSix Inc.

    Vertically integrated chemistry company reporting 2Q26 financial results and 2026 outlook, including dividend declaration.

  • Erin Kane

    CEO quoted on performance drivers and outlook.

Related articles

$ASIXHigh

What AdvanSix (ASIX) Said on Its Q3 Earnings Call

AdvanSix (ASIX) reported Q3 operating cash flow rose $21M to $48M, with capital spending down $8M. The company expects improved demand and tighter supply for ammonium sulfate in early 2027. Free cash flow for 2026 is projected to break even, excluding a potential $18M tax credit refund. ASIX anticipates $90M in 2026 capital spending and $80M for 2027, with a broader view in February. Project CENTURY, a $98M ammonia expansion, awaits USDA funding approval.

Med

AdvanSix Inc. Q3 2026 Earnings Call Summary

AdvanSix Inc. reported Q3 2026 earnings, highlighting 17% favorable pricing offsetting $65M raw material cost increases. The company maintained high operating rates, optimized production, and reduced fixed costs. It expects Q4 price-over-raws headwinds and a 2027 ammonium sulfate supply shortage. AdvanSix secured a $47M USDA grant for Project CENTURY and closed a $425M credit facility.

$ASIXMedAI 8/10

AdvanSix (ASIX) Q3 2026 Earnings Call Transcript

AdvanSix (ASIX) reported Q3 2026 sales of $431M, up 15% YoY, driven by pricing. Adjusted EBITDA was $15M, down $10M YoY. Ammonia sales expected to rise 25% for the year. Nylon resin production up 5% YoY. Company focuses on cost reduction, operational excellence, and disciplined capital deployment.